FDA Approves First PSMA-targeted PET Imaging Agent for Prostate Cancer
News
The U.S. Food and Drug Administration (FDA) has approved Gallium 68 PSMA-11 (Ga 68 PSMA-11) as a positron emission tomography or PET imaging agent for men with prostate cancer. The ... Read more